Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease
- PMID: 31618555
- DOI: 10.1056/NEJMc1910735
Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease
Comment in
-
Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease. Reply.N Engl J Med. 2019 Oct 17;381(16):1596-1597. doi: 10.1056/NEJMc1910735. N Engl J Med. 2019. PMID: 31618556 No abstract available.
Comment on
-
Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease.N Engl J Med. 2019 Jun 27;380(26):2518-2528. doi: 10.1056/NEJMoa1903076. Epub 2019 May 20. N Engl J Med. 2019. PMID: 31112379 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical